Skip to content

Medpace Voice

Tag: Neurodegenerative

Company Spotlight

Medpace Expands Medical Leadership Team with Expert in Parkinson’s Disease 

  • October 20, 2025

Neuroscience and Cognition and brings extensive expertise in the design and execution of Parkinson’s disease research. Additionally, she has over...

Clinical Development

Top 3 Key Takeaways from ENCALS 2025

  • July 1, 2025

Medpace Medical and Clinical Operations Experts Share Key Insights from the ENCALS Meeting

Clinical Development

Exciting CNS Breakthroughs: Where the Promise Lies

  • November 2, 2018

In a recent PharmaVoice article "Brain Wave: Breakthroughs Bring New Hope to CNS", Dr. Rick Scheyer, Vice-President, Medical Affairs at Medpace, provides comment on the state of…